These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2453874)
21. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies. Louie DS; Liang JP; Owyang C Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681 [TBL] [Abstract][Full Text] [Related]
22. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo. Niederau M; Niederau C; Strohmeyer G; Grendell JH Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767 [TBL] [Abstract][Full Text] [Related]
23. Effect of a new cholecystokinin receptor antagonist CR 1392 on caerulein-induced acute pancreatitis in rats. Otsuki M; Tani S; Okabayshi Y; Nakamura T; Fujii M; Fujisawa T; Baba S; Itoh H Pancreas; 1989; 4(2):237-43. PubMed ID: 2474165 [TBL] [Abstract][Full Text] [Related]
24. Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. I. Bile duct obstruction with and without pancreatic duct obstruction. Murayama KM; Samuel I; Toriumi Y; Solomon TE; Turkelson CM; Joehl RJ J Surg Res; 1993 Feb; 54(2):126-31. PubMed ID: 7683071 [TBL] [Abstract][Full Text] [Related]
25. Effects of the cholecystokinin receptor antagonist L-364,718 on experimental pancreatitis in mice. Silverman M; Ilardi C; Bank S; Kranz V; Lendvai S Gastroenterology; 1989 Jan; 96(1):186-92. PubMed ID: 2462522 [TBL] [Abstract][Full Text] [Related]
26. Role of cholecystokinin-A (CCK-A) receptor in pancreatic regeneration after pancreatic duct occlusion: a study in rats lacking CCK-A receptor gene expression. Miyasaka K; Ohta M; Tateishi K; Jimi A; Funakoshi A Pancreas; 1998 Mar; 16(2):114-23. PubMed ID: 9510132 [TBL] [Abstract][Full Text] [Related]
27. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate. Kimura K; Tominaga K; Fujii M; Saito T; Kasai H Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035 [TBL] [Abstract][Full Text] [Related]
28. The role of cholecystokinin in the pathogenesis of acute pancreatitis in the isolated pancreas preparation. Nordback IH; Clemens JA; Cameron JL Surgery; 1991 Mar; 109(3 Pt 1):301-6. PubMed ID: 1705726 [TBL] [Abstract][Full Text] [Related]
29. Influence of the CCK-antagonist loxiglumide on bile-induced experimental pancreatitis. Leonhardt U; Seidensticker F; Fussek M; Stöckmann F; Creutzfeldt W Int J Pancreatol; 1991 Sep; 10(1):73-80. PubMed ID: 1757732 [TBL] [Abstract][Full Text] [Related]
30. Role of endogenous cholecystokinin in the regeneration of pancreatic tissue after acute hemorrhagic pancreatitis in rats. Song W; Yamaguchi H; Nakano I; Kimura T; Nawata H Fukuoka Igaku Zasshi; 1996 Jan; 87(1):14-22. PubMed ID: 8820983 [TBL] [Abstract][Full Text] [Related]
31. Time-course changes in pancreatic laboratory and morphologic parameters in two different acute pancreatitis models in rats. Takács T; Czakó L; Jármay K; Hegyi P; Pozsár J; Marosi E; Pap A; Lonovics J Acta Med Hung; 1994; 50(1-2):117-30. PubMed ID: 7543670 [TBL] [Abstract][Full Text] [Related]
32. Effect of FK480, a CCK-A receptor antagonist, on spontaneously developed chronic pancreatitis in WBN/Kob rats. Ito H; Sogabe H; Kuno M; Satoh Y; Ogawa T; Konishi K; Yoshida K Pancreas; 1998 Oct; 17(3):295-300. PubMed ID: 9788545 [TBL] [Abstract][Full Text] [Related]
33. Possible role of cholecystokinin in the development of acute pancreatitis in rats. Shinya H; Fujimura M Nihon Geka Hokan; 1989 Jan; 58(1):3-17. PubMed ID: 2802913 [TBL] [Abstract][Full Text] [Related]
34. Effects of the cholecystokinin receptor antagonist L-364,718 on pancreatitis induced by a deficient in choline and supplemented with ethionine (CDE) diet in the rat. Manso MA; Rodriguez AI; Garcia-Montero AC; De Dios I Arch Physiol Biochem; 1995 Aug; 103(4):410-5. PubMed ID: 8548474 [TBL] [Abstract][Full Text] [Related]
35. Cholecystokinin-1 receptor protein up-regulation during pancreatic regeneration after acute haemorrhagic pancreatitis in rats. Yoshikawa H; Nakamura H; Tashiro M; Yamaguchi T; Taguchi M; Fukumitsu K; Otsuki M Eur J Clin Invest; 2004 Jul; 34(7):498-507. PubMed ID: 15255787 [TBL] [Abstract][Full Text] [Related]
36. Protective action of luminal bile salts in necrotizing acute pancreatitis in mice. Gomez G; Townsend CM; Green DW; Rajaraman S; Uchida T; Greeley GH; Soloway RD; Thompson JC J Clin Invest; 1990 Jul; 86(1):323-31. PubMed ID: 1694866 [TBL] [Abstract][Full Text] [Related]
37. Role of endogenous and exogenous cholecystokinin in experimental acute pancreatitis induced in rats by the duodenal loop technique. Ha SS; Satake K; Hiura A J Gastroenterol; 1996 Jun; 31(3):404-13. PubMed ID: 8726833 [TBL] [Abstract][Full Text] [Related]
38. Effect of a new cholecystokinin receptor antagonist (KSG 504) on the early stage of the healing process in acute pancreatitis induced in rats by the closed duodenal loop technique. Ha S; Satake K; Hiura A; Sowa M; Nishiwaki H Pancreas; 1994 Jul; 9(4):501-7. PubMed ID: 7524065 [TBL] [Abstract][Full Text] [Related]
39. Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility. Bock MG; DiPardo RM; Rittle KE; Evans BE; Freidinger RM; Veber DF; Chang RS; Chen TB; Keegan ME; Lotti VJ J Med Chem; 1986 Oct; 29(10):1941-5. PubMed ID: 3761313 [TBL] [Abstract][Full Text] [Related]
40. Reduced cholecystokinin mediates the inhibition of pancreatic growth induced by bile salts. Gomez G; Townsend CM; Green DW; Rajaraman S; Greeley GH; Thompson JC Am J Physiol; 1990 Jul; 259(1 Pt 1):G86-92. PubMed ID: 1695489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]